1. (valid email required)

cforms contact form by delicious:days

Archive for December, 2009

CRi Announces Results of Signaling Pathway Protein Study

Study Demonstrates Platform’s Potential Use in Biomarker Analysis in Clinical Studies

Woburn, Massachusetts – December 1, 2009

Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, today announced the results of a study demonstrating for the first time the capability to detect and automatically measure key activity indicators of cancer cell signal transduction pathways in intact tissue. The study demonstrates the potential use of CRi’s imaging and analysis platform in clinical studies to assess biomarkers for patient selection, drug response, and molecular diagnostic development. Results from a collaborative study between researchers at CRi, the Novartis Institutes for Biomedical Research, and Cell Signaling Technology (CST), was presented during the recent American Association for Cancer Research (AACR) International Conference on Molecular Targets and Cancer Therapeutics in Boston.

Detection and quantitation of multiple protein biomarkers on a single tissue section, and the ability to correlate their changes with clinical outcomes is critical to targeted drug and molecular diagnostic development. Current methods used to detect multiple pathway proteins, such as microarray analysis, lack contextual precision within cells due to destruction of tissue integrity.

In this study, researchers used CRi imaging systems to separate and quantitate overlapping signals in a single tissue section for three critical signaling proteins (phospho-Akt, -ERK, and S6 Ribosomal Protein) overcoming this significant barrier. The systems are able to distinguish the activation of these proteins that are expressed simultaneously from overlapping locations. Background autofluorescence signal was detected and subtracted using CRi’s unique autofluorescence-removal capability.

The study combines the use of multiplexed immunofluorescence staining protocols with CRi’s automated slide analysis system, Vectra™. This system uses multispectral imaging to isolate marker signals from one another and from autofluorescence, and CRi’s learn-by-example image analysis package, inForm™, for automatically segmenting images and extracting data from cells-of-interest.

inForm’s automated and reliable image analysis capabilities detect tumor cells and segment associated cellular compartments, after training on less than 10% of images. The results of the study support the application of multiplexed immunofluorescence staining protocols with Vectra and inForm in routine clinical studies. Currently, protocols and workflow procedures with these systems are being implemented for evaluation of patient samples.

“The results of this study demonstrate the power of combining CRi’s inForm and Vectra along with high quality antibodies from Cell Signaling Technology, to reveal unique, high-value information from tissue slides,” said Cliff Hoyt, a study author and chief technology officer at CRi. “The results point to a growing role for our optical imaging and analysis technologies in clinical biomarker analysis for developing targeted drug therapies and molecular diagnostics.”

The study, is titled, “Tissue Cytometry Platform for Quantitating Multiple Signaling Pathways Proteins in Intact Tissue”. In addition to Hoyt, the authors on the study include: David Yang, J. Carl Barrett, Humphrey Gardner of the Novartis Institutes for Biomedical Research; and Randall K. Wetzel of Cell Signaling Technology. For more information on the study visit:


About CRi, Inc.

Cambridge Research & Instrumentation (CRi) develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented systems enable researchers and clinicians to quantitate multiple disease and drug response markers in intact tissue samples, at a cellular level or in living small animals. CRi’s products integrate a unique multispectral imaging technology with proprietary image analysis algorithms to achieve unparalleled accuracy and sensitivity, rapidly and cost-effectively. CRi’s award-winning systems include Nuance™ for multispectral imaging on brightfield and fluorescence microscopes; inForm™ automated image analysis software; Vectra™ for high-throughput slide imaging and analysis; and Maestro™ for in-vivo optical imaging. Learn more at www.cri-inc.com.

About Cell Signaling Technology

Established in 1999, Cell Signaling Technology (CST) is a privately owned company with over 300 employees. CST has expertise and the market leadership position in the development and commercialization of phospho-specific and total protein antibodies as well as assays for pathway analysis. Aberrant signaling within these pathways has been implicated in various diseases including cancer, diabetes and neurodegenerative diseases.

For more information, contact:

Cambridge Research & Instrumentation, Inc. (CRi)

Cathy Boutin, 781-935-9099

Marketing Manager

Email: cboutin@cri-inc.com


CCA Digital Media/PR Group

Jamie Bull, 508-620–0791 x12

Digital Media Strategist

Email: jamieb@commcreative.com

Latest News

Dynasil Corporation of America (NASDAQ:DYSL) is pleased to announce our new website is now available at www.dynasil.com

NWN Corporation Obtains Cisco’s Elite Partnership Status In Their OpenDNS Certification Partner Program

NWN Corporation Named to CRN’s 2016 IT Solutions Provider 500 List

ACT Government leads in waste innovation

Zenoss Names NWN Corporation as Managed IT Service Provider of The Year For Second Year In a Row

Latest Newsletters

July 2016 – Mass Capital Announces a New Investment in The Cadmus Group, Inc.

April 2016 – Andrew DeLorey joins Mass Capital

March 2016 – Mass Capital announces a new investment in Valet Park of America

January 2016 – Mass Capital announces a new investment in Phillips Screw Company

November 2015 – Mass Capital announces a new investment in Triumvirate Environmental


July 2016

June 2016

May 2016

April 2016

March 2016

February 2016

January 2016

December 2015

November 2015

October 2015

September 2015

August 2015

July 2015

June 2015

May 2015

April 2015

March 2015

February 2015

January 2015

October 2014

March 2014

February 2014

January 2014

December 2013

October 2013

September 2013

August 2013

July 2013

March 2013

February 2013

November 2012

October 2012

September 2012

August 2012

July 2012

June 2012

May 2012

April 2012

March 2012

February 2012

January 2012

December 2011

November 2011

October 2011

September 2011

August 2011

July 2011

June 2011

May 2011

April 2011

March 2011

February 2011

December 2010

November 2010

October 2010

September 2010

August 2010

July 2010

May 2010

April 2010

February 2010

January 2010

December 2009

November 2009

October 2009

September 2009

August 2009

July 2009

June 2009

May 2009

April 2009

February 2009

January 2009

December 2008

November 2008

October 2008

September 2008

July 2008

June 2008

April 2008

January 2008

November 2007

October 2007

September 2007